Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Existe información en español para pacientes y cuidadores, para acceder, haga clic sobre “Select” al lado de “I am a U.S. Patient / Caregiver”.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PLEGISOL Principal Display Panel (cardioplegic solution for cardiac perfusion)

PRINCIPAL DISPLAY PANEL - 1000 mL Bag

1000 mL
NDC 0409-7969-11

PLEGISOL®

HOSPIRA'S CARDIOPLEGIC SOLUTION
FOR CARDIAC PERFUSION

WARNING:
NOT FOR INTRAVENOUS INJECTION

EACH 100 mL CONTAINS SODIUM CHLORIDE 643 mg;
CALCIUM CHLORIDE, DIHYDRATE 17.6 mg;
MAGNESIUM CHLORIDE, HEXAHYDRATE 325.3 mg;
POTASSIUM CHLORIDE 119.3 mg. MAY CONTAIN
HCl AND/OR NaOH for pH ADJUSTMENT.
304 mOsmol/LITER (CALC.). pH 3.8 (3.5 TO 3.9).

PRIOR TO SODIUM BICARBONATE ADDITION
ELECTROLYTES PER 1000 mL (NOT INCLUDING IONS
FOR pH ADJUSTMENT): SODIUM 110 mEq; CHLORIDE
160 mEq; POTASSIUM 16 mEq; CALCIUM 2.4 mEq;
MAGNESIUM 32 mEq. STERILE, NONPYROGENIC.

ADDITION OF 10 mL of 8.4% SODIUM
BICARBONATE INJECTION, USP, HOSPIRA LIST
4900, IS REQUIRED PRIOR TO USAGE TO ADJUST
THE pH TO APPROXIMATELY 7.8 AT ROOM
TEMPERATURE. MIX THOROUGHLY.

STORE SOLUTION CONTAINING BICARBONATE UNDER
REFRIGERATION. DO NOT STORE LONGER THAN
24 HOURS. ADDITIVES MAY BE INCOMPATIBLE.
CONSULT WITH PHARMACIST, IF AVAILABLE. WHEN
INTRODUCING ADDITIVES, USE ASEPTIC TECHNIQUE,
MIX THOROUGHLY AND DO NOT STORE. USE ONLY IF
SOLUTION IS CLEAR AND CONTAINER IS
UNDAMAGED. USUAL DOSAGE: SEE INSERT. MUST
NOT BE USED IN SERIES CONNECTION.

RX ONLY
3
v
CONTAINS DEHP
Hospira

DISTRIBUTED BY HOSPIRA, INC.,
LAKE FOREST, IL 60045 USA

IM-4462
14480901

Principal Display Panel - 1000 mL Bag

PRINCIPAL DISPLAY PANEL - 1000 mL Overwrap Label

CAUTION

Use aseptic technique.
It is required to add 10 mL of 8.4% Sodium Bicarbonate
Injection, USP, Hospira List 4900, prior to use (see insert).
Affix additive label over label on flexible container.

TO OPEN — TEAR AT NOTCH

DO NOT REMOVE FROM OVERWRAP UNTIL READY
FOR USE. AFTER REMOVING THE OVERWRAP,
CHECK FOR MINUTE LEAKS BY SQUEEZING
CONTAINER FIRMLY. IF LEAKS ARE FOUND, DISCARD
SOLUTION AS STERILITY MAY BE IMPAIRED.
STORE AT 20 TO 25°C (68 TO 77°F). [SEE USP
CONTROLLED ROOM TEMPERATURE.]
PROTECT FROM FREEZING. SEE INSERT. NOT MADE
WITH NATURAL RUBBER LATEX

IM-4497
14481201

PRINCIPAL DISPLAY PANEL -  - 1000 mL Overwrap Label

PRINCIPAL DISPLAY PANEL - 1000 mL Additive Label

1000 mL
Additive Label

NDC 0409-7969-11

PLEGISOL®
HOSPIRA'S CARDIOPLEGIC SOLUTION
WARNING: NOT FOR INTRAVENOUS INJECTION.

Patient _________________ Location ________________

No. ____________________________________________

10 mL of 8.4% Sodium Bicarbonate Injection, USP, Hospira List 4900, has
been added to this solution to adjust the pH to approximately 7.8 at room
temperature.

Electrolytes per 1000 mL: Sodium 120 mEq, potassium 16 mEq, magnesium
32 mEq, calcium 2.4 mEq, chloride 160 mEq, bicarbonate 10 mEq.

324 mOsmol/liter (calc.)
Approx. pH 7.8

Time additive made ______________ Date _____________

Store solution containing bicarbonate under refrigeration. Do not store
longer than 24 hours. Cool to 4° C prior to use.
Usual dosage: See insert. Discard unused portion.

RX ONLY

14481301
CL-0180

Distributed by Hospira, Inc., Lake Forest, IL 60045 USA

PRINCIPAL DISPLAY PANEL - 1000 mL Additive Label
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event